TSBX vs. TIL, DTIL, ELUT, IKNA, JATT, ALGS, ATHA, GRTS, PASG, and CGTX
Should you be buying Turnstone Biologics stock or one of its competitors? The main competitors of Turnstone Biologics include Instil Bio (TIL), Precision BioSciences (DTIL), Elutia (ELUT), Ikena Oncology (IKNA), JATT Acquisition (JATT), Aligos Therapeutics (ALGS), Athira Pharma (ATHA), Gritstone bio (GRTS), Passage Bio (PASG), and Cognition Therapeutics (CGTX). These companies are all part of the "biological products, except diagnostic" industry.
Instil Bio (NASDAQ:TIL) and Turnstone Biologics (NASDAQ:TSBX) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, dividends, community ranking, media sentiment, risk, analyst recommendations, valuation and institutional ownership.
Turnstone Biologics has higher revenue and earnings than Instil Bio.
Instil Bio received 90 more outperform votes than Turnstone Biologics when rated by MarketBeat users. Likewise, 51.98% of users gave Instil Bio an outperform vote while only 50.00% of users gave Turnstone Biologics an outperform vote.
In the previous week, Instil Bio's average media sentiment score of 0.00 beat Turnstone Biologics' score of -0.45 indicating that Turnstone Biologics is being referred to more favorably in the news media.
Instil Bio's return on equity of 0.00% beat Turnstone Biologics' return on equity.
Instil Bio presently has a consensus target price of $36.00, suggesting a potential upside of 239.62%. Turnstone Biologics has a consensus target price of $19.00, suggesting a potential upside of 588.41%. Given Instil Bio's higher possible upside, analysts plainly believe Turnstone Biologics is more favorable than Instil Bio.
60.6% of Instil Bio shares are owned by institutional investors. Comparatively, 52.5% of Turnstone Biologics shares are owned by institutional investors. 54.7% of Instil Bio shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Summary
Instil Bio beats Turnstone Biologics on 6 of the 11 factors compared between the two stocks.
Get Turnstone Biologics News Delivered to You Automatically
Sign up to receive the latest news and ratings for TSBX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TSBX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Turnstone Biologics Competitors List
Related Companies and Tools
